RTOG 1008: A Randomized Phase II Study of Adjuvant Concurrent Radiation and Chemotherapy Versus Radiation Alone in Resected High-Risk Malignant Salivary Gland Tumors
Head and Neck Cancers
This is a clinical trial of cisplatin that will be administered by IV which is standard of care and radiation therapy that will be administered standard of care.
IRB Protocol #
MONICA ROBISCHON at (720) 848-0661 or MONICA.ROBISCHON@UCDENVER.EDU
University of Colorado Hospital University of Colorado Hospital
Eligibility and Other Participant Information
What To Expect : A screening period to determine eligibility. A treatment period that can last up to 6 to 7 weeks. A follow up period will consist of clinic visits for for 3 to 6 months for the first 4 years and then phone contact afterwards. // Eligibility criteria include but are not limited to 18 years or older with salivary gland tumors.Eligibility criteria include but are not limited to 18 years or older with salivary gland tumors.